Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma

Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..

BACKGROUND: Opisthorchis viverrini (Ov) infection-induced cholangiocarcinoma (CCA) is a major public health problem in northeastern Thailand. Praziquantel was shown to prevent CCA development in an Ov-infected hamster model; however, the molecular mechanism remains unknown.

MATERIALS AND METHODS: In this study, we used a hamster model with Ov and N-nitrosodimethylamine-induced CCA to study the mechanisms of praziquantel action. The liver tissues from the hamsters with and without praziquantel treatment were analyzed using 1H nuclear magnetic resonance spectroscopy.

RESULTS: A total of 14 metabolites were found to be significantly different between the two groups. Furthermore, the combination of acetate, inosine and sarcosine was shown to exert an anti-inflammatory effect through interleukin-6 inhibition in a macrophage cell line, suggesting a mechanism by which praziquantel may prevent inflammation caused by Ov, cholangiocyte transformation and further CCA develpoment.

CONCLUSION: These findings might avail the development of a preventive strategy for CCA in high-risk populations.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:18

Enthalten in:

Cancer genomics & proteomics - 18(2021), 1 vom: 08. Jan., Seite 29-42

Sprache:

Englisch

Beteiligte Personen:

Prommajun, Pattama [VerfasserIn]
Phetcharaburanin, Jutarop [VerfasserIn]
Namwat, Nisana [VerfasserIn]
Klanrit, Poramate [VerfasserIn]
Sa-Ngiamwibool, Prakasit [VerfasserIn]
Thanee, Malinee [VerfasserIn]
Dokduang, Hasaya [VerfasserIn]
Kittirat, Yingpinyapat [VerfasserIn]
Li, Jia V [VerfasserIn]
Loilome, Watcharin [VerfasserIn]

Links:

Volltext

Themen:

6490C9U457
Anthelmintics
Anti-inflammation
Cholangiocarcinoma
Journal Article
Metabolic profiling
Nuclear magnetic resonance spectroscopy.
Praziquantel

Anmerkungen:

Date Completed 20.08.2021

Date Revised 10.02.2022

published: Print

Citation Status MEDLINE

doi:

10.21873/cgp.20239

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM319834956